Estrogen receptor alpha gene analysis in osteoporosis and familial osteoporosis

Author： Fountas L.   Anapliotou M.   Kominakis A.   Sekeris C.   Kassi E.   Moutsatsou P.  

Publisher： Springer Publishing Company

ISSN： 0937-941X

Source： Osteoporosis International, Vol.15, Iss.12, 2004-12, pp. : 948-956

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Osteoporosis

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 38, Iss. 10, 1990-10 ,pp. : 1153-1158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Osteoporosis

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 30, Iss. 2, 1982-02 ,pp. : 127-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Osteoporosis

By  

Reviews in Clinical Gerontology, Vol. 3, Iss. 2, 1993-05 ,pp. : 135-146

Cambridge University Press

Access to resources Recommend Favorite

Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis

By Palacios Santiago  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1553-1563

Informa Healthcare

Access to resources Recommend Favorite

Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis – a clinical update on efficacy and safety

By Deal Chad L   Draper Michael W  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 199-210

Future Medicine

Access to resources Recommend Favorite